AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11826728 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated finger disability (loss of four fingers in the preferred hand and the thumb in the nonpreferred hand)
Number of subjects: 10
Study 11826728 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical restraint (torso restrained or unrestrained)
Number of subjects: 10
Study 11826728 — intervention group
Group type: EXPERIMENTAL
Intervention: Type of control and height of control location
Number of subjects: 10
Study 9802965 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg nebulized glyceryl trinitrate (GTN)
Number of subjects: 18
Study 9802965 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 18
Study 7916551 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium 0.5 mg.kg‐1
Number of subjects: 40
Study 7916551 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 0.1 mg.kg‐1
Number of subjects: 40
Study 7916551 — intervention group
Group type: COMPARATOR
Intervention: Control (blood withdrawn before muscle relaxants)
Number of subjects: 40
Study 2681580 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous terbutaline (IURT)
Number of subjects: 50
Study 2681580 — intervention group
Group type: COMPARATOR
Intervention: Standard interventions (Control)
Number of subjects: 50
Study 4469041 — intervention group
Group type: EXPERIMENTAL
Intervention: Norethandrolone (Nilevar)
Number of subjects: 0
Study 4469041 — intervention group
Group type: EXPERIMENTAL
Intervention: D-thyroxine (Choloxin)
Number of subjects: 0
Study 30742386 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined effect of magnetolaser therapy (MLT) and red light (10 procedures per course)
Number of subjects: 120
Study 30742386 — intervention group
Group type: COMPARATOR
Intervention: Basic therapeutic complex (medicamentous therapy, prostate massage, diet therapy, therapeutic gymnastics)
Number of subjects: 120
Study 26279411 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin (GTN) 0.4 mg/h
Number of subjects: 35
Study 26279411 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil citrate 50 mg
Number of subjects: 35
Study 26279411 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 26279411 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal arterial blood pressure
Number of subjects: 35
Study 26279411 — intervention group
Group type: EXPERIMENTAL
Intervention: MCA-PI
Number of subjects: 35
Study 24912462 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) combined with venlafaxine XR, 12 sessions
Number of subjects: 42
Study 24912462 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) combined with venlafaxine XR
Number of subjects: 42
Study 24912462 — intervention group
Group type: COMPARATOR
Intervention: Control group (European Americans receiving combined treatment)
Number of subjects: 42
Study 23214249 — intervention group
Group type: COMPARATOR
Intervention: Walsh or Poor method for handling the dorsal venous complex (DVC)
Number of subjects: 100
Study 23214249 — intervention group
Group type: EXPERIMENTAL
Intervention: Three additional hemostatic procedures including prophylactic suture, ligation of vascular bundle, and absorbable sutures
Number of subjects: 100
Study 20212016 — intervention group
Group type: EXPERIMENTAL
Intervention: High Protein Diet (HP)
Number of subjects: 76
Study 20212016 — intervention group
Group type: EXPERIMENTAL
Intervention: High Carbohydrate Diet (HC)
Number of subjects: 76
Study 18402097 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-cured calcium hydroxide (Ca(OH)2)
Number of subjects: 20
Study 18402097 — intervention group
Group type: COMPARATOR
Intervention: Diluted formocresol (FC)
Number of subjects: 20
Study 18402097 — intervention group
Group type: COMPARATOR
Intervention: Radiographic scoring
Number of subjects: 20
Study 15811138 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein diet (25 E% protein, 45 E% carbohydrate)
Number of subjects: 50
Study 15811138 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate diet (58 E% carbohydrate, 12 E% protein)
Number of subjects: 50
Study 11759109 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN + ribavirin
Number of subjects: 55
Study 11759109 — intervention group
Group type: COMPARATOR
Intervention: IFN
Number of subjects: 55
Study 9140633 — intervention group
Group type: EXPERIMENTAL
Intervention: New atypical antipsychotic
Number of subjects: 23
Study 9140633 — intervention group
Group type: COMPARATOR
Intervention: Baseline examination
Number of subjects: 23
Study 7951124 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX (Methotrexate) for low risk of GVHD
Number of subjects: 73
Study 7951124 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX + CsA (Cyclosporine A) for high risk of GVHD
Number of subjects: 73
Study 7951124 — intervention group
Group type: COMPARATOR
Intervention: Retrospective controls (MTX + CsA for 1 year)
Number of subjects: 73
Study 7951124 — intervention group
Group type: EXPERIMENTAL
Intervention: BuCY conditioning
Number of subjects: 73
Study 7951124 — intervention group
Group type: EXPERIMENTAL
Intervention: CY/TBI conditioning
Number of subjects: 73
Study 7951124 — intervention group
Group type: COMPARATOR
Intervention: Retrospective controls
Number of subjects: 73
Study 3300133 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 400 mg orally 1 hour before abortion and again 4 and 8 hours after
Number of subjects: 118
Study 3300133 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study 3300133 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 118
Study 2568793 — intervention group
Group type: EXPERIMENTAL
Intervention: Iotrolan
Number of subjects: 72
Study 2568793 — intervention group
Group type: COMPARATOR
Intervention: Iohexol
Number of subjects: 72
Study 31987237 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Thai Massage (TTM)
Number of subjects: 140
Study 31987237 — intervention group
Group type: COMPARATOR
Intervention: Thai Massage with Herbal Compress (TMH)
Number of subjects: 140
Study 31627728 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 ml of 0.4% ropivacaine (Group T)
Number of subjects: 104
Study 31627728 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Group C)
Number of subjects: 104
Study 28902593 — intervention group
Group type: EXPERIMENTAL
Intervention: PFO closure plus long-term antiplatelet therapy
Number of subjects: 663
Study 28902593 — intervention group
Group type: COMPARATOR
Intervention: Antiplatelet therapy alone
Number of subjects: 663
Study 28902593 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulation
Number of subjects: 663
Study 28902593 — intervention group
Group type: EXPERIMENTAL
Intervention: PFO closure
Number of subjects: 663
Study 28902593 — intervention group
Group type: EXPERIMENTAL
Intervention: PFO closure, oral anticoagulation, and antiplatelet therapy
Number of subjects: 663
Study 25395283 — intervention group
Group type: EXPERIMENTAL
Intervention: Figitumumab (20 mg/kg) plus erlotinib (150 mg/day)
Number of subjects: 579
Study 25395283 — intervention group
Group type: COMPARATOR
Intervention: Erlotinib alone
Number of subjects: 579
Study 23886531 — intervention group
Group type: EXPERIMENTAL
Intervention: Epicardial adipose tissue (EAT) and thoracic periaortic adipose tissue (TAT) volumes measured by computed tomography
Number of subjects: 100
Study 23886531 — intervention group
Group type: EXPERIMENTAL
Intervention: Perivascular fat depots (EAT and TAT)
Number of subjects: 100
Study 23886531 — intervention group
Group type: EXPERIMENTAL
Intervention: Perivascular fat
Number of subjects: 100
Study 22236538 — intervention group
Group type: EXPERIMENTAL
Intervention: LC-IOES
Number of subjects: 226
Study 22236538 — intervention group
Group type: COMPARATOR
Intervention: LC-LCBDE
Number of subjects: 226
Study 19820793 — intervention group
Group type: EXPERIMENTAL
Intervention: CustomCornea
Number of subjects: 50
Study 19820793 — intervention group
Group type: COMPARATOR
Intervention: Zyoptix
Number of subjects: 50
Study 16755855 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxonidine
Number of subjects: 36
Study 16755855 — intervention group
Group type: COMPARATOR
Intervention: Prestarium
Number of subjects: 36
Study 15004870 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior modification (60-70 minutes, once a week for 8 weeks)
Number of subjects: 62
Study 15004870 — intervention group
Group type: COMPARATOR
Intervention: Control group (no management or treatment)
Number of subjects: 62
Study 11520714 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline inhalation via a pressurized metered-dose inhaler
Number of subjects: 92
Study 11520714 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline inhalation
Number of subjects: 92
Study 11520714 — intervention group
Group type: EXPERIMENTAL
Intervention: sRaw bronchodilator response
Number of subjects: 92
Study 11520714 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 9764456 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticlopidine, 250 mg b.d. for 7 days before surgery and continued for 28 days after surgery
Number of subjects: 258
Study 9764456 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 258
Study 8154176 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg ASA daily
Number of subjects: 223
Study 8154176 — intervention group
Group type: COMPARATOR
Intervention: 1000 mg ASA daily
Number of subjects: 223
Study 3230904 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexibility before
Number of subjects: 48
Study 3230904 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexibility after
Number of subjects: 48
Study 3230904 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexibility before and after
Number of subjects: 48
Study 3230904 — intervention group
Group type: COMPARATOR
Intervention: Control group (inactive)
Number of subjects: 48
Study 31701133 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (0.25 mg/kg)
Number of subjects: 43
Study 31701133 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 31694699 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy-based program designed to enhance resilience, focusing on emotion regulation through cognitive reappraisal, delivered in four bi-weekly 120-min sessions.
Number of subjects: 140
Study 31694699 — intervention group
Group type: COMPARATOR
Intervention: Control group participating in a series of group discussions.
Number of subjects: 140
Study 31694699 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy-based program.
Number of subjects: 140
Study 28651159 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab and ipilimumab combination therapy
Number of subjects: 0
Study 28651159 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab monotherapy
Number of subjects: 0
Study 28651159 — intervention group
Group type: COMPARATOR
Intervention: Ipilimumab alone
Number of subjects: 0
Study 26354104 — intervention group
Group type: EXPERIMENTAL
Intervention: Lingual tonsillectomy (LT)
Number of subjects: 108
Study 26354104 — intervention group
Group type: COMPARATOR
Intervention: Hyoid suspension type 2 (HS) + radiofrequency treatment of the base of the tongue (RFT TB)
Number of subjects: 108
Study 26354104 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous tonsillectomy
Number of subjects: 108
Study 23128427 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-intensity treadmill exercise (50 minutes at 40%-50% of heart rate reserve)
Number of subjects: 67
Study 23128427 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching and resistance exercises (2 sets of 10 repetitions on each leg on 3 resistance machines)
Number of subjects: 67
Study 23128427 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-intensity treadmill exercise (30 minutes at 70%-80% of heart rate reserve)
Number of subjects: 67
Study 23128427 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-intensity treadmill exercise
Number of subjects: 67
Study 23128427 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-intensity treadmill exercise
Number of subjects: 67
Study 23128427 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching and resistance exercises
Number of subjects: 67
Study 21831718 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction pemetrexed and cisplatin followed by maintenance pemetrexed
Number of subjects: 0
Study 21831718 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin plus paclitaxel plus bevacizumab followed by maintenance bevacizumab
Number of subjects: 0
Study 19781209 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol 500 mg b.i.d for 3 days before and after intervention
Number of subjects: 205
Study 19781209 — intervention group
Group type: COMPARATOR
Intervention: Control group (no probucol treatment)
Number of subjects: 205
Study 19781209 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol 500 mg b.i.d
Number of subjects: 205
Study 16388882 — intervention group
Group type: EXPERIMENTAL
Intervention: self-regulatory skills training focused on exercise planning strategies
Number of subjects: 198
Study 16388882 — intervention group
Group type: COMPARATOR
Intervention: standard-care control group
Number of subjects: 198
Study 16388882 — intervention group
Group type: EXPERIMENTAL
Intervention: self-regulatory skills training
Number of subjects: 198
Study 14513873 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg prednisolone/day
Number of subjects: 20
Study 14513873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 11751733 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg once daily)
Number of subjects: 16
Study 11751733 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 9431834 — intervention group
Group type: EXPERIMENTAL
Intervention: Benazepril 20 mg
Number of subjects: 0
Study 9431834 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9431834 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol 8 mg
Number of subjects: 0
Study 9431834 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 160 mg
Number of subjects: 0
Study 8516658 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride 30 mg/day
Number of subjects: 147
Study 8516658 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study 8516658 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide 30 mg/day
Number of subjects: 147
Study 8516658 — intervention group
Group type: COMPARATOR
Intervention: Domperidone 30 mg/day
Number of subjects: 147
Study 3320783 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (with methyldopa or propranolol if necessary)
Number of subjects: 785
Study 3320783 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 785
Study 29065271 — intervention group
Group type: EXPERIMENTAL
Intervention: STG graft
Number of subjects: 62
Study 29065271 — intervention group
Group type: EXPERIMENTAL
Intervention: ST4 graft
Number of subjects: 62
Study 27880789 — intervention group
Group type: EXPERIMENTAL
Intervention: Rumination-Focused Cognitive Behavior Therapy (RFCBT) for 8 weeks
Number of subjects: 33
Study 25097754 — intervention group
Group type: EXPERIMENTAL
Intervention: SUB‐B (10,000 AUN/ml)
Number of subjects: 74
Study 25097754 — intervention group
Group type: COMPARATOR
Intervention: Stal‐B (initial phase 10 I.R./ml and maintenance phase 300 I.R./ml)
Number of subjects: 74
Study 25097754 — intervention group
Group type: EXPERIMENTAL
Intervention: SUB‐B and Stal‐B
Number of subjects: 74
Study 22634532 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human endostatin (RHES) for ten days
Number of subjects: 15
Study 22634532 — intervention group
Group type: COMPARATOR
Intervention: Negative control (no RHES)
Number of subjects: 15
Study 19955506 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline 6 mg/kg IV, followed by 1.5 mg x kg(‐1) x h(‐1)
Number of subjects: 8
Study 19955506 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 8
Study 17565524 — intervention group
Group type: EXPERIMENTAL
Intervention: Colorectal cancer screening test
Number of subjects: 1050
Study 17565524 — intervention group
Group type: EXPERIMENTAL
Intervention: Visiting a doctor for a checkup
Number of subjects: 1050
Study 17565524 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal or family history of colon polyps or cancer
Number of subjects: 1050
Study 17565524 — intervention group
Group type: EXPERIMENTAL
Intervention: Asking for a colorectal cancer screening test
Number of subjects: 1050
Study 17565524 — intervention group
Group type: COMPARATOR
Intervention: Financial concerns
Number of subjects: 1050
Study 16525946 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 17
Study 16525946 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 17
Study 12164999 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized version of the Center for Epidemiologic Studies Depression Scale (CES-D)
Number of subjects: 43
Study 12164999 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer experience
Number of subjects: 43
Study 12164999 — intervention group
Group type: EXPERIMENTAL
Intervention: Age, education, and cognitive function
Number of subjects: 43
Study 10442940 — intervention group
Group type: EXPERIMENTAL
Intervention: Particulate dentin and plaster of paris combination
Number of subjects: 10
Study 8559961 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity sessions
Number of subjects: 42
Study 8559961 — intervention group
Group type: COMPARATOR
Intervention: Guidance in nutrition and behavior modification
Number of subjects: 42
Study 2151369 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate (TAM/HD‐MPA)
Number of subjects: 170
Study 2151369 — intervention group
Group type: COMPARATOR
Intervention: Continuous tamoxifen (TAM)
Number of subjects: 170
Study 883328 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide local excision
Number of subjects: 370
Study 883328 — intervention group
Group type: COMPARATOR
Intervention: Standard radical mastectomy
Number of subjects: 370
Study 883328 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (wide local excision and radical mastectomy)
Number of subjects: 370
Study 883328 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage II cancer patients
Number of subjects: 370
Study 31987546 — intervention group
Group type: EXPERIMENTAL
Intervention: Straight-line group (SLG) - 1 × 15 repetitions of 20-meter sprints in line
Number of subjects: 26
Study 31987546 — intervention group
Group type: EXPERIMENTAL
Intervention: Change-of-direction group (CODG) - 1 × 15 repetitions of 20-meter sprints with two changes in each repetition
Number of subjects: 26
Study 30744113 — intervention group
Group type: EXPERIMENTAL
Intervention: High-cholesterol meal
Number of subjects: 0
Study 30744113 — intervention group
Group type: COMPARATOR
Intervention: Low-cholesterol meal
Number of subjects: 0
Study 26954588 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based cognitive behavioral intervention (7 sessions)
Number of subjects: 105
Study 26906139 — intervention group
Group type: EXPERIMENTAL
Intervention: Art group
Number of subjects: 39
Study 26906139 — intervention group
Group type: EXPERIMENTAL
Intervention: Diversional music group
Number of subjects: 39
Study 26906139 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study 24665014 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintendo Wii balance board training for 4 weeks
Number of subjects: 20
Study 24665014 — intervention group
Group type: COMPARATOR
Intervention: Usual sports activities (Control)
Number of subjects: 20
Study 24665014 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral stance tests (both groups)
Number of subjects: 20
Study 22538676 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic colectomy (SILC)
Number of subjects: 50
Study 22538676 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic colectomy (CLC)
Number of subjects: 50
Study 20164333 — intervention group
Group type: EXPERIMENTAL
Intervention: Activation of anterior VMPFC
Number of subjects: 0
Study 20164333 — intervention group
Group type: EXPERIMENTAL
Intervention: Activation of posterior VMPFC
Number of subjects: 0
Study 18931227 — intervention group
Group type: EXPERIMENTAL
Intervention: Dural puncture with a 25‐gauge Whitacre spinal needle before epidural analgesia
Number of subjects: 80
Study 18931227 — intervention group
Group type: COMPARATOR
Intervention: Standard epidural technique without prior dural puncture
Number of subjects: 80
Study 15979283 — intervention group
Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (group I)
Number of subjects: 27
Study 15979283 — intervention group
Group type: COMPARATOR
Intervention: Control subjects with eutrophia (group II)
Number of subjects: 27
Study 15979283 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with other illnesses but normal digestive tracts (group III)
Number of subjects: 27
Study 11936545 — intervention group
Group type: EXPERIMENTAL
Intervention: Actual items presentation
Number of subjects: 9
Study 11936545 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictures of the items presentation
Number of subjects: 9
Study 11936545 — intervention group
Group type: EXPERIMENTAL
Intervention: Spoken-name presentation
Number of subjects: 9
Study 10411194 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasally administered trivalent LAIV vaccine
Number of subjects: 4561
Study 10411194 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4561
Study 7574055 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (preoperative bolus of bupivacaine followed by an infusion of bupivacaine)
Number of subjects: 54
Study 7574055 — intervention group
Group type: EXPERIMENTAL
Intervention: Group MB (preoperative bolus of epidural bupivacaine and morphine followed by an infusion of morphine and bupivacaine)
Number of subjects: 54
Study 7574055 — intervention group
Group type: EXPERIMENTAL
Intervention: Group M (preoperative bolus of epidural morphine followed by an infusion of morphine)
Number of subjects: 54
Study 7574055 — intervention group
Group type: EXPERIMENTAL
Intervention: Group P (preoperative bolus of intravenous morphine followed by intravenous patient‐controlled morphine postoperatively)
Number of subjects: 54
Study 1309127 — intervention group
Group type: EXPERIMENTAL
Intervention: Assisted hatching by zona drilling using acidic Tyrode's solution on embryos with thick zonae (> 15 microns).
Number of subjects: 330